Is anti-D immunoglobulin still a frontline treatment option for immune thrombocytopenia?

Jenny M. Despotovic, Cindy E. Neunert

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

A 5-year-old boy presents with platelet count of 2×10(9)/L and clinical and laboratory evidence of immune thrombocytopenia. He has epistaxis and oral mucosal bleeding. Complete blood count reveals isolated thrombocytopenia without any decline in hemoglobin and he is Rh+. You are asked if anti-D immunoglobulin is an appropriate initial therapy for this child given the 2010 Food and Drug Administration "black-box" warning.

Original languageEnglish (US)
Pages (from-to)283-285
Number of pages3
JournalHematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program
Volume2013
DOIs
Publication statusPublished - Jan 1 2013

    Fingerprint

ASJC Scopus subject areas

  • Hematology

Cite this